Vivesto AB
556332-6676ActiveSwedish drug developer focusing on novel cancer treatments for humans and animals.
Biotechnology Companyvivesto.com
Yleiskatsaus
- 5–9
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 1988
- Perustettu
Avainpäättäjät
Robert Maiorana
Acting Chief Financial Officer
Roger Tell
Member of the Board
Pål Ryfors
Member of the Board
Christer Hasslebäck
Member of the Nomination Committee
+6 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Vivesto is a Swedish drug development company dedicated to creating new treatment options for challenging cancers that present significant medical needs. The organization focuses its research and development efforts on advancing projects from preclinical stages through to clinical proof-of-concept....